Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 231,992,920 papers from all fields of science
Search
Sign In
Create Free Account
0.5 ML Leuprolide Acetate 60 MG/ML Prefilled Syringe [Eligard]
Known as:
ELIGARD KIT
, 0.5 ML Eligard 60 MG/ML Prefilled Syringe
, LEUPROLIDE ACETATE (ELIGARD) 30MG (4 MONTH) INJ,SUSP,LA
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
15 relations
Drug Allergy
Eligard
Endometrial Neoplasms
Endometriosis
Expand
Broader (1)
Leuprolide Acetate
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Eligard® (leuprorelina): falta de eficacia clínica debida a errores durante el proceso de reconstitución y administración del medicamento
M. Sanz
2014
Corpus ID: 68334152
Se han notificado al Sistema Español de Farmacovigilancia varios casos de falta de eficacia clínica asociada a errores durante el…
Expand
2013
2013
Neues zur Behandlung des metastasierten Prostatakarzinoms
A. Omlin
,
S. Gillessen
,
Arnoud J. Templeton
2013
Corpus ID: 79572615
Eine wachsende Anzahl von Medikamenten mit unterschiedlichem Wirkmechanismus hat in den letzten drei Jahren zur Verbesserung des…
Expand
2013
2013
Du nouveau sur le traitement du carcinome prostatique métastatique
Aurelius Omlin
,
S. Gillessen
,
Arnoud J. Templeton
2013
Corpus ID: 80511357
Depuis notre aperçu dans Swiss Medical Forum 2010 (2010;10[28–29]:483–5), il y a eu une petite révolution dans le domaine du…
Expand
Review
2009
Review
2009
Improving Flexibility and Quality of Life for Your Patients: A Must?
A. Heidenreich
2009
Corpus ID: 71637296
2009
2009
Traitement antiandrogénique pour le cancer de la prostate localisé
J. Belche
2009
Corpus ID: 53820854
Population étudiée 89 877 patients enregistrés dans une base de données épidémiologiques (Surveillance, Epidemiology and End…
Expand
2008
2008
Cost-efficacy analysis of hormonal treatments for advanced prostate cancer
S. Iannazzo
,
L. Pradelli
2008
Corpus ID: 56544907
Introduction: prostatic cancer is the second more frequent cancer in Italy (after lung cancer) and is the third cancer-related…
Expand
2006
2006
WITHDRAWN: Corrigendum to: “How Good do Current LHRH Agonists Control Testosterone? Can this be Improved with Eligard®?” [European Urology Supplements 4/8 (2005) 1–41]
B. Tombal
,
R. Berges
2006
Corpus ID: 71534314
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE